KOKiyomitsu Oyanagi

Kiyomitsu Oyanagi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kiyomitsu Oyanagi has a total of 105 co-authors. Here are the top co-authors by number of shared publications:

  • Akiyoshi Kakita

    Department of Pathology, Brain Research Institute, Niigata University , Niigata

    3 shared publications
  • Asa Nakahara

    Division of Neuropathology, Department of Brain Disease Research, Shinshu University School of Medicine, Nagano, Japan

    3 shared publications
  • Emi Suzuki‐Kouyama

    Division of Neuropathology, Department of Brain Disease Research, Shinshu University School of Medicine, Nagano, Japan

    3 shared publications
  • Yoshiki Sekijima

    Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine

    3 shared publications
  • Ikuru Yazawa

    Faculty of Health and Medical Sciences, Tokoha University, 1230 Miyakoda-chou, Kita-Ku, Hamamatsu, Shizuoka 431-2102, Japan

    2 shared publications
  • Jun Nakayama

    Department of Molecular Pathology, Shinshu University Graduate School of Medicine, Nagano, Japan

    2 shared publications

Latest Publications

  • Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Estimation of pathological lesion stage from brain images

    by Michiaki Kinoshita, Kiyomitsu Oyanagi, Akira Matsushima, Yasufumi Kondo, Shigeki Hirano, Keisuke Ishizawa, Kenji Ishihara, Seishi Terada, Teruhiko Inoue, Ikuru Yazawa, et al.


  • Open Access

    Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold

    by Chao Qi, Bert M. Verheijen, Yasumasa Kokubo, Yang Shi, Stephan Tetter, Alexey G. Murzin, Asa Nakahara, Satoru Morimoto, Marc Vermulst, Ryogen Sasaki, et al.

    The amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC) of the island of Guam and the Kii peninsula of Japan is a fatal neurodegenerative disease of unknown cause that is characterized by the presence of abundant filamentous tau inclusions in brains and spinal cords. Here, we used electron cryo-microscopy to determine the structures of tau filaments from the cerebral cortex of three cases of ALS/PDC from Guam and eight cases from Kii, as well as from the spinal cord of two of the Guam cases. Tau filaments had the chronic traumatic encephalopathy (CTE) fold, with variable amounts of Type I and Type II filaments. Paired helical tau filaments were also found in three Kii cases and tau filaments with the corticobasal degeneration fold in one Kii case. We identified a new Type III CTE tau filament, where protofilaments pack against each other in an antiparallel fashion. ALS/PDC is the third known tauopathy with CTE-type filaments and abundant tau inclusions in cortical layers II/III, the others being CTE and subacute sclerosing panencephalitis. Because these tauopathies are believed to have environmental causes, our findings support the hypothesis that ALS/PDC is caused by exogenous factors.


  • The large neuron involvement in the neostriatum in Lewy body diseases

    by Kiyomitsu Oyanagi, Hideki Hayashi, Mitsunori Yamada, Akiyoshi Kakita

  • The neostriatum in polyglutamine diseases: preferential decreases in large neurons in dentatorubral‐pallidoluysian atrophy and Machado‐Joseph disease and in small neurons in Huntington disease

    by Kiyomitsu Oyanagi, Hiroshi Shimizu, Mitsunori Yamada, Akiyoshi Kakita

    The presence of polyglutamine‐immunoreactive deposits in neurons of the neostriatum has been reported in dentatorubral‐pallidoluysian atrophy (DRPLA), Machado‐Joseph disease (MJD), and Huntington disease (HD). However, among these diseases, precise quantitative investigations on neurons have been performed only for HD. Changes in the number of neurons and the immunohistological features of polyglutamine deposits in the caudate head and putamen were examined in six patients with DRPLA, three with MJD, and four with HD. In the neostriatum in DRPLA, the numbers of large and small neurons were reduced to 33–38% and 48–68% relative to controls, respectively, whereas the corresponding figures in MJD were 19–26% and 65–76%, respectively, and those in HD were 34–35% and 12–16%, respectively. In DRPLA, 2–55% of neurons remaining in the neostriatum showed diffuse nuclear accumulation of polyglutamine, in contrast to 3–20% in MJD and a few percent in HD. These findings indicate that, in the neostriatum, a decrease in the number of small neurons is predominant in HD, whereas a decrease in the number of large neurons is predominant in DRPLA and MJD. Thus, it is suggested that disease processs differ among polyglutamine diseases.


  • Spread of vimentin‐immunoreactive cells within the plaque‐like lesion in the spinal anterior horn of a patient with post‐poliomyelitis syndrome

    by Akiyo Hineno, Kiyomitsu Oyanagi, Takuhiro Yoshida, Yasuhiro Sakai, Hiroyuki Kanno, Yoshiki Sekijima

    A Japanese man in the present study experienced acute weakness in his right leg as a two year old. The strength in his leg gradually recovered and developed, and he could play golf and climb mountains up to around the age of 50. From approximately 55 years of age, he became unable to stand up from a stooped position. Muscle weakness and atrophy spread to his right arm, and an electromyography revealed a neurogenic pattern in his lower and upper extremities. The patient was diagnosed as having post-poliomyelitis syndrome (PPS). Numbness in both the legs and pain in the buttocks occurred after 60 years of age. Computed tomography and magnetic resonance imaging at that time revealed spondylosis and protrusion of an osteophye in lower thoracic vertebrae compressing the second lumbar segment of the spinal cord. He died of malignant lymphoma and acute interstitial pneumonia at 80 years of age. Pathological examination revealed transverse myelopathy at the second lumbar segment of the spinal cord and total necrosis. The anterior horn and the intermediate zone of the third and fourth lumbar segments of the spinal cord on the right side were atrophic and diffusely gliotic. An oval-shaped plaque-like lesion was observed in the right anterior horn at the third and fourth lumbar segments of the spinal cord. Neurons and synaptophysin immunoreactivity had completely disappeared in the plaque-like lesion. A striking spread of vimentin-immunoreactive cells was found corresponding to the lesion, while glial fibrillary acidic protein-immunoreactive astrocytes existed evenly in the anterior horn and intermediate zone on both sides of the third and fourth lumber segments of the spinal cord. Virological examination using the autopsied materials was negative for poliovirus. Neither transactivation response DNA-binding protein of 43 kDa-immunoreactive inclusion nor Bunina body was seen in the spinal cord. The present paper demonstrates new findings of a noteworthy response of the vimentin-immunoreactive cells within the peculiar “plaque-like lesion” in the PPS.

  • Open Access

    Pathologic basis of the preferential thinning of thecorpus callosum in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)

    by Michiaki Kinoshita, Kiyomitsu Oyanagi, Yasufumi Kondo, Keisuke Ishizawa, Kenji Ishihara, Mari Yoshida, Teruhiko Inoue, Yoshio Mitsuyama, Kunihiro Yoshida, Mitsunori Yamada, et al.


  • Adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and Nasu–Hakola disease: lesion staging and dynamic changes of axons and microglial subsets

    by Kiyomitsu Oyanagi, Michiaki Kinoshita, Emi Suzuki‐Kouyama, Teruhiko Inoue, Asa Nakahara, Mika Tokiwai, Nobutaka Arai, Jun‐Ichi Satoh, Naoya Aoki, Kenji Jinnai, et al.

    The brains of 10 Japanese patients with adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) encompassing hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD) and eight Japanese patients with Nasu–Hakola disease (N‐HD) and five age‐matched Japanese controls were examined neuropathologically with special reference to lesion staging and dynamic changes of microglial subsets. In both diseases, the pathognomonic neuropathological features included spherically swollen axons (spheroids and globules), axon loss and changes of microglia in the white matter. In ALSP, four lesion stages based on the degree of axon loss were discernible: Stage I, patchy axon loss in the cerebral white matter without atrophy; Stage II, large patchy areas of axon loss with slight atrophy of the cerebral white matter and slight dilatation of the lateral ventricles; Stage III, extensive axon loss in the cerebral white matter and dilatation of the lateral and third ventricles without remarkable axon loss in the brainstem and cerebellum; Stage IV, devastated cerebral white matter with marked dilatation of the ventricles and axon loss in the brainstem and/or cerebellum. Internal capsule and pontine base were relatively well preserved in the N‐HD, even at Stage IV, and the swollen axons were larger with a higher density in the ALSP. Microglial cells immunopositive for CD68, CD163 or CD204 were far more obvious in ALSP, than in N‐HD, and the shape and density of the cells changed in each stage. With progression of the stage, clinical symptoms became worse to apathetic state, and epilepsy was frequently observed in patients at Stages III and IV in both diseases. From these findings, it is concluded that (i) shape, density and subsets of microglia change dynamically along the passage of stages and (ii) increase of IBA‐1‐, CD68‐, CD163‐ and CD204‐immunopositive cells precedes loss of axons in ALSP.


  • Open Access

    Axonal TDP‐43 aggregates in sporadic amyotrophic lateral sclerosis

    by Tomoya Onozato, Asa Nakahara, Emi Suzuki‐Kouyama, Akiyo Hineno, Takuji Yasude, Toshitsugu Nakamura, Hiroyuki Yahikozawa, Masahide Watanabe, Katsuhiko Kayanuma, Hideo Makishita, et al.

    Aims: Axonal aggregates of phosphorylated (p-) transactive response DNA-binding protein 43 kDa (TDP-43) in sporadic amyotrophic lateral sclerosis (sALS) were examined in relation to propagation of the protein in the nervous system. Methods: Brains and spinal cords of Japanese patients with sALS and control subjects were examined immunohistochemically using formalin-fixed paraffin-embedded specimens with special reference to the topographical distribution, microscopic features, presynaptic aggregates, and correlation between the aggregates in axons and the clinical course. Results: (i) Aggregates of p-TDP-43 were frequently present in axons of the hypoglossal and facial nerve fibres and the spinal anterior horn cells. (ii) Aggregates of p-TDP-43 in the axons showed two characteristic microscopic features - dash-like granuloreticular aggregates (GRAs) and massive aggregates (MAs). (iii) MAs were surrounded by p-neurofilaments, but p-neurofilament immunnoreactivity decreased at the inside of axons with GRAs. (iv) Patients showing MAs and GRAs had a relatively shorter clinical course than patients without the aggregates. (v) Some neurones in the red nucleus in patients were surrounded by synapses containing p-and p-independent (i)-TDP-43, and almost all neurones had lost their nuclear TDP-43 immunoreactivity; 17% of those neurones in the red nucleus also had TDP-43-immuno-positive neuronal cytoplasmic inclusions, but no postsynaptic p-TDP-43 deposition was evident. Conclusions: There are two types of axonal p-TDP-43 aggregates, MAs and GRAs, located predominantly in the facial and hypoglossal nuclei and anterior horn cells. These aggregates may influence the function of neurones, and presynaptic aggregates of the protein induce loss of p-i-TDP-43 in the nuclei of postsynaptic neurones.


  • “Gliomatosis encephali” as a novel category of brain tumors by the first autopsy case report of gliomatosis cerebelli

    by Asa Nakahara, Toshikazu Yoshida, Masanobu Yazawa, Takashi Ehara, Jun Nakayama, Akiyoshi Kakita, Ryosuke Ogura, Mika Asakawa, Emi Suzuki‐Kouyama, Kiyomitsu Oyanagi

    Gliomatosis cerebri is a rare diffuse glioma that is neither mass‐forming nor necrotic, and does not disrupt existing structures. Gliomatosis occurring in the cerebellum is known as gliomatosis cerebelli, and only three such cases examined by biopsy have been reported. Here we describe the first autopsy findings of a patient who was diagnosed as having gliomatosis in the cerebellum. Neuropathological examination identified the tumor cells as being positive for glial fibrillary acidic protein, vimentin and nestin, with atypical nuclei that were cashew‐nut‐ or dishcloth‐gourd‐shaped. These tumor cells were dense in the right cerebellum, but also spread broadly throughout the brain including the left cerebrum and optic nerve. Mitotic figures were frequently seen in the cerebellum, brain stem and cerebrum. Scherer's secondary structures were evident not only in the cerebellum but also the cerebrum. No necrosis, microvascular proliferation or destruction of anatomical structures was detected in the whole brain. Differences in the origin of the tumors of the gliomatoses cerbri and cerebelli suggests these tumors are different types of brain tumors. Thus the findings support that the gliomatosis cerebelli is a novel type of brain tumor classification. Furthermore, by the similarities of the histological features among the tumors, it appears appropriate to establish a novel category of “gliomatosis encephali” which includes both gliomatosis cerebri and gliomatosis cerebelli.


  • Oxidized galectin-1 advances the functional recovery after peripheral nerve injury

    by Toshihiko Kadoya, Kiyomitsu Oyanagi, Emiko Kawakami, Mitsuhiro Hasegawa, Yoshimasa Inagaki, Yoshiaki Sohma, Hidenori Horie